Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,015,089 papers from all fields of science
Search
Sign In
Create Free Account
GW 1516
Known as:
GW-1516
, GW1516
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
GW 501516
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Monitoring Solution Structures of Peroxisome Proliferator-Activated Receptor β/δ upon Ligand Binding
Rico Schwarz
,
D. Tänzler
,
C. Ihling
,
A. Sinz
PLoS ONE
2016
Corpus ID: 9260220
Peroxisome proliferator-activated receptors (PPARs) have been intensively studied as drug targets to treat type 2 diabetes, lipid…
Expand
2013
2013
Biomedical Advancements in Injury Recovery, Performance Enhancement, and Mechanical Assistance Applied to Athletics
Matthew Russell
2013
Corpus ID: 108065026
.......................................................................................5 Introduction…
Expand
2012
2012
Telmisartan as metabolic modulator: a new perspective in sports doping?
F. Sanchis-Gomar
,
G. Lippi
Journal of Strength and Conditioning Research
2012
Corpus ID: 11701637
The World Antidoping Agency (WADA) has introduced some changes in the 2012 prohibited list. Among the leading innovations to the…
Expand
2012
2012
Detection of PPARδ agonists GW1516 and GW0742 and their metabolites in human urine.
T. Sobolevsky
,
M. Dikunets
,
I. Sukhanova
,
E. Virus
,
G. Rodchenkov
Drug Testing and Analysis
2012
Corpus ID: 205760951
Peroxisome proliferator-activated receptor-δ (PPARδ) agonists are the drug candidates with potential performance-enhancing…
Expand
2012
2012
Abstract 70: PPARdelta Agonist GW1516 Attenuates Diet-Induced Dyslipidemia, Insulin Resistance and Aortic Inflammation in Ldlr-/- Mice
Lazar A. Bojic
,
D. E. Telford
,
Brian G. Sutherland
,
C. Sawyez
,
J. Y. Edwards
,
M. Huff
2012
Corpus ID: 92835707
Objective: The peroxisome proliferator-activated receptor (PPAR) delta has been implicated in systemic lipid homeostasis and…
Expand
2010
2010
Characterization of two major urinary metabolites of the PPARδ-agonist GW1516 and implementation of the drug in routine doping controls
M. Thevis
,
I. Möller
,
+5 authors
W. Schänzer
Analytical and Bioanalytical Chemistry
2010
Corpus ID: 45094266
AbstractSince January 2009, the list of prohibited substances and methods of doping as established by the World Anti-Doping…
Expand
2007
2007
Method for increasing the exercise capacity
ロナルド エム. エバンス,
,
マイケル ダウンズ
,
ビハン エイ. ナーカー
,
ユ ルースティー.
,
ワン ヨン−シュ
2007
Corpus ID: 146041103
In this specification, by administering PPARδ agonist to a subject (e.g., GW1516) in combination with exercise program, it…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE